Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Sinan, Koca"'
Autor:
David Sinan Koca, Vladimir Kolpakov, Jana Ihlow, Maximilian von Laffert, Katharina Erb-Eigner, Hermann Herbst, Karen Kriese, Leonille Schweizer, Eckart Bertelmann
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 2, Pp 1467-1484 (2024)
The orbital manifestation of a solitary fibrous tumor (SFT) is exceptionally rare and poses specific challenges in diagnosis and treatment. Its rather exceptional behavior among all SFTs comprises a high tendency towards local recurrence, but it rare
Externí odkaz:
https://doaj.org/article/fe0b74bf76f24a629106545b51006671
Autor:
İrem Peker Eyüboğlu, Sinan Koca, Betül Çelik, Gökçe Güllü Amuran, M. Ümit Uğurlu, Özkan Alan, Tuğba Akın Telli, Perran Fulden Yumuk, Mustafa Akkiprik
Publikováno v:
International Journal of Breast Cancer, Vol 2024 (2024)
Conclusion: Our study suggests that telomere length in cfDNA may be a useful biomarker for predicting therapy response and possible reoccurrence of the disease in breast cancer patients.
Externí odkaz:
https://doaj.org/article/148c3ac22dcd42daa9cb6baaccc3afdd
Autor:
Tuğba AKIN TELLİ, Nalan AKGÜL BABACAN, Özkan ALAN, Mehmet Akif ÖZTÜRK, Rahib HASANOV, Sinan KOCA, Süleyman HALİL, Eda TANRIKULU ŞİMŞEK, Tuğba BAŞOĞLU, Özlem ERCELEP, Faysal DANE, Perran Fulden YUMUK
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 10, Iss 1, Pp 74-79 (2022)
Aim:DR-70 is a newly developed immunoassay that detects fibrin degradation products in blood. We aimed to evaluate ability of DR-70 in monitoring treatment response in advanced gastrointestinal (GI) cancers.Materials and Methods:We prospectively enro
Externí odkaz:
https://doaj.org/article/0eecd9d0c2d943feb4b11316cac36178
Autor:
Ayşe Demirci, Cemil Bilir, Burcu Gülbağcı, İlhan Hacıbekiroğlu, İbrahim V. Bayoğlu, İrem Bilgetekin, Sinan Koca, Havva Y. Çınkır, Nadiye Akdeniz, Deniz Gül, Ceyhun Varım, Umut Demirci, Berna Öksüzoğlu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract To compare enzalutamide (E) and abiraterone acetate (AA) in terms of efficacy, survival and to characterize prognostic factors affecting survival in metastatic castration-resistant prostate cancer (mCRPC) patients. A total of 250 patients tr
Externí odkaz:
https://doaj.org/article/2f1961a10d9b47f5b41b353c34cd4036
Autor:
Sinan Koca, Esra Koca, Ilker N. Okten, Fatma FC. Orengül, Akın Oztürk, Melike Ozçelik, Abdilkerim Oyman, Ibrahim Çil, Mahmut Gümüş
Publikováno v:
Heliyon, Vol 8, Iss 8, Pp e10142- (2022)
Introduction: Although cancer patients have a high risk of exposing COVID-19 and developing severe complications, they have to receive active treatment. We aimed to determine the psychological conditions of cancer patients and shed light on the estab
Externí odkaz:
https://doaj.org/article/3fa24aa1639848028cdd6693471cf0a2
Autor:
Ozkan Alan, Tugba Akin Telli, Bilge Aktas, Sinan Koca, Ilker Nihat Ökten, Rahib Hasanov, Tugba Basoglu, Rukiye Arikan, Nazim Can Demircan, Ozlem Ercelep, Serap Kaya, Mustafa Umit Ugurlu, Handan Kaya, Nalan Akgul Babacan, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Purpose Neoadjuvant chemotherapy is the standard front-line treatment modality in locally advanced breast cancer. Achieving pathological complete response (pCR) is a significant prognostic factor for prolonged disease-free and overall surviv
Externí odkaz:
https://doaj.org/article/9854984b8d9e4981ac56e556ec7b4c9c
Autor:
sinan koca
Publikováno v:
Eurasian Journal of Medical Investigation.
Autor:
sinan koca
Publikováno v:
Eurasian Journal of Medicine and Oncology.
Autor:
Ahmet Bilici, Sinan Koca, Mustafa Karaagac, Sabin Goktas Aydin, Emrah Eraslan, Muhammed Ali Kaplan, Birol Ocak, Sema Sezgin Goksu, Semra Paydas, Fahri Akgul, Sumeyye Derin, Yakup Ergun, Emre Yekeduz, Cihan Erol, Deniz Tataroglu Ozyukseler, Atike Gokcen Demiray, Mustafa Karaca, Zeynep Gulsum Guc, Serkan Menekse, Havva Yesil Cinkir, Ozge Gumusay, Abdullah Sakin, Ozlem Ozkul, Hacer Demir, Dilek Erdem, Mehmet Besiroglu, Olcun Umit Unal, Ramazan Acar, Lokman Koral, Suleyman Sahin, Teoman Sakalar, Aykut Bahceci, Ahmet Ozveren, Ulug Mutlu Gunaydin, Mehmet Metin Seker, Veli Sunar, Pinar Dal, Mehmet Artac, Serdar Turhal
Aim: Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS). Patients and methods: This multicenter study is based on retrospective review of hospital medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e475dde06decc907f161d14d4d0f2ae4
https://avesis.deu.edu.tr/publication/details/c895112d-5502-4614-a59b-a819d23aebc3/oai
https://avesis.deu.edu.tr/publication/details/c895112d-5502-4614-a59b-a819d23aebc3/oai
Autor:
Sadettin Kilickap, Mutlu Hizal, Ahmet Gulmez, Okan Avci, Burak Yasin Aktas, Havva Yesil Cinkir, Emir Celik, Mustafa Gürbüz, Berna Oksuzoglu, Ali Murat Tatli, Gulhan Ipek Deniz, Cihan Erol, Erdem Sen, Fulden Yumuk, A İlhan, Şebnem Yücel, Semra Paydas, Ozkan Alan, Engin Kut, Fatih Karatas, Atakan Demir, Murat Ayhan, Bulent Yalcin, Halil Taskaynatan, Tugba Basoglu, Serkan Menevse, Deniz Tataroğlu Özyükseler, Nadiye Akdeniz, Sinan Koca, Mustafa Karaagac, Burak Bilgin, Didem Sener Dede, Mehmet Ali Nahit Sendur, Muhammed Bulent Akinci, Izzet Dogan, Ahmet Demirkazik, Teoman Sakalar
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 147:2145-2152
The new second-generation tyrosine kinase inhibitors (TKIs) have superior survival outcome and worse toxicity profile when compared with first-generation TKIs according to the results of clinical trials. However, there are limited studies that invest